Daniel Bernstein

Dr. Daniel Bernstein is the Alfred Woodley Salter and Mabel G. Salter Endowed Professor of Pediatrics at Stanford University, with a primary appointment in the Department of Pediatrics - Cardiology. He serves as Associate Dean for Curriculum and Scholarship at the Stanford University School of Medicine (since 2018) and previously led the Children's Heart Center at Packard Children's Hospital (2001-2011) and the Division of Pediatric Cardiology (1994-2011). His research focuses on pediatric heart failure, mitochondrial biology, and congenital heart disease mechanisms, with major contributions to understanding hypertrophic cardiomyopathy and cardiac transplant outcomes.

Education: MD from NYU Grossman School of Medicine (1978), followed by residency and fellowship training at Albert Einstein College of Medicine/Montefiore Medical Center and UCSF. Board certifications in Pediatrics and Pediatric Cardiology.

Research interests include mitochondrial dysfunction in disease, right ventricular failure mechanisms, and iPSC-derived cardiomyocyte modeling of genetic cardiomyopathies. His lab investigates beta-adrenergic signaling pathways and develops biomarkers for post-transplant lymphoproliferative disorder (PTLD) in pediatric transplant recipients.

Award-winning educator with the 2013 Stanford Best Lecture Award and 2014 Stanford Stole. Serves on the Ronald McDonald House at Stanford Board (2011-2016). Leads clinical trials on anthracycline cardiotoxicity and PTLD biomarkers.

Key publications include genomic analyses of congenital heart disease, mitochondrial dysfunction studies, and long-term outcomes in pediatric heart transplantation. Active in translational research bridging basic science and clinical cardiology.